pyruvic acid and stavudine

pyruvic acid has been researched along with stavudine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Koopmans, PP; ter Hofstede, HJ; Willems, HL	1
de Baar, MP; de Ronde, A; Ruiter, JP; Tebas, P; Timmermans, EC; Wanders, RJ	1
Baron, E; Frank, I; Lebrecht, D; Lo Re, V; McComsey, GA; Mounzer, K; O'Riordan, M; Walker, UA	1

Trials

1 trial(s) available for pyruvic acid and stavudine

Article	Year
Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Apr-15, Volume: 46, Issue:8 Topics: Adipose Tissue; Adult; Anti-HIV Agents; Body Composition; Bone Density; DNA, Mitochondrial; Female; Genotype; HIV Infections; Humans; Lactic Acid; Leukocytes, Mononuclear; Male; Middle Aged; Pyruvic Acid; Stavudine	2008

Article

Year

Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Apr-15, Volume: 46, Issue:8

Topics: Adipose Tissue; Adult; Anti-HIV Agents; Body Composition; Bone Density; DNA, Mitochondrial; Female; Genotype; HIV Infections; Humans; Lactic Acid; Leukocytes, Mononuclear; Male; Middle Aged; Pyruvic Acid; Stavudine

2008

Other Studies

2 other study(ies) available for pyruvic acid and stavudine

Article	Year
Serum L-lactate and pyruvate in HIV-infected patients with and without presumed NRTI-related adverse events compared to healthy volunteers. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2004, Volume: 29, Issue:1 Topics: Adult; Anti-HIV Agents; DNA, Mitochondrial; Female; HIV Infections; HIV-1; Humans; Lactic Acid; Male; Mitochondria; Pyruvic Acid; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine	2004
Real-time nucleic acid sequence-based amplification assay to quantify changes in mitochondrial DNA concentrations in cell cultures and blood cells from HIV-infected patients receiving antiviral therapy. Clinical chemistry, 2006, Volume: 52, Issue:6 Topics: Anti-HIV Agents; Base Sequence; Blood Platelets; Cell Nucleus; Cells, Cultured; Didanosine; DNA, Mitochondrial; Drug Therapy, Combination; Feasibility Studies; Fibroblasts; HIV Infections; Humans; Indinavir; Lactic Acid; Lamivudine; Leukocytes, Mononuclear; Nucleic Acid Amplification Techniques; Pyruvic Acid; Stavudine; Zalcitabine	2006

Article

Year

Serum L-lactate and pyruvate in HIV-infected patients with and without presumed NRTI-related adverse events compared to healthy volunteers.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2004, Volume: 29, Issue:1

Topics: Adult; Anti-HIV Agents; DNA, Mitochondrial; Female; HIV Infections; HIV-1; Humans; Lactic Acid; Male; Mitochondria; Pyruvic Acid; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine

2004

Real-time nucleic acid sequence-based amplification assay to quantify changes in mitochondrial DNA concentrations in cell cultures and blood cells from HIV-infected patients receiving antiviral therapy.

Clinical chemistry, 2006, Volume: 52, Issue:6

Topics: Anti-HIV Agents; Base Sequence; Blood Platelets; Cell Nucleus; Cells, Cultured; Didanosine; DNA, Mitochondrial; Drug Therapy, Combination; Feasibility Studies; Fibroblasts; HIV Infections; Humans; Indinavir; Lactic Acid; Lamivudine; Leukocytes, Mononuclear; Nucleic Acid Amplification Techniques; Pyruvic Acid; Stavudine; Zalcitabine

2006